Item 2.02Results of Operations and Financial Condition.
On
In accordance with General Instruction B.2 of Form 8-K, the information included in this Item 2.02, including Exhibit 99.1 hereto, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 8.01Other Events.
On
Item 9.01Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number Description 99.1 Press release issued byAprea Therapeutics, Inc. datedMay 15, 2023 . 99.2 Corporate Presentation (May 2023 ). Cover Page Interactive Data File (embedded within the inline XBRL 104 document).
© Edgar Online, source